Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical Oncology ...

For decades, biology textbooks taught that DNA’s story could be told with a single image: two elegant strands twisting in a ...

At the core of CTOAM's work, Morand explains, is a precision oncology process that integrates multiple diagnostic tools into ...

Foster + Partners architect Ben Dobbin blends nature and technology in projects like Apple Park in California, The Dalmore’s Luminary Series and his own digital art.

I’m the fastest designer in the country,” designer Rajdeep Ranawat begins the conversation, and we can’t help but agree. He ...

“Climate resilience will be one of the major sustainability topics in 2026, grabbing the attention of everyone from investors ...

There's a new phrase one encounters a lot in public debates lately: the "US kill line". It has gone viral not just because of ...

OpenAI is quietly redrawing its internal map around a simple but radical bet: the future of artificial intelligence will be ...

On January 10, 1920, the Treaty of Versailles officially took effect, bringing World War I’s peace settlement into force and ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.